ICMR frames first guidelines for AI application in healthcare, research

ICMR frames first guidelines for AI application in healthcare, research

The Indian Council of Medical Research (ICMR) has framed a set of ethical guidelines for the application of artificial intelligence (AI) in biomedical research and healthcare.

ICMR’s Ethical Guidelines for the Application of Artificial Intelligence in Biomedical Research and Healthcare are the first of their kind in the country.

A document drafted by the Department of Health Research (DHR) and ICMR’s AI Cell explains that AI for health depends largely on data obtained from human participants. It raises concerns related to potential bias, data handling, interpretation, autonomy, risk minimization, professional competence, data sharing, and confidentiality.

Also read: AI study suggests over 10 million elderly people in India may have dementia

“It is, therefore, imperative to have an ethical framework that addresses issues specific to AI for biomedical research and healthcare,” the guidelines states.

Ethical challenges

The adoption of AI technology in healthcare is growing in India. However, AI as data-driven technology has many potential ethical challenges, including algorithmic transparency and explicability, clarity on liability, accountability and oversight, bias and discrimination, said ICMR Director General Dr Rajiv Behl.

“The DHR-ICMR AI Cell has identified the need to develop these guiding ethical principles concerning artificial intelligence and machine learning-based tools.

“These guidelines will provide the ethical framework for the development of AI-based tools, which will benefit all stakeholders, including innovators, developers, patients, technologists, researchers, healthcare professionals, ethics committees, sponsors and funding agencies involved in research related to AI in biomedical research and healthcare,” he said.

Also read: AI can help India become developed nation by 2047: Modi

Intended for all stakeholders

National Technical Advisory Group on Immunisation (NTAGI) chief Dr NK Arora said the purpose of the guideline is to provide an ethical framework to help with the development, deployment, and adoption of AI-based solutions for biomedical research and healthcare delivery.

The guidelines are intended for all stakeholders involved in research on artificial intelligence in healthcare, including creators, developers, technicians, researchers, clinicians, ethics committees, institutions, sponsors, and funding organizations.

It includes separate sections addressing ethical principles for AI in health, guiding principles for stakeholders, the ethics review process, governance of artificial intelligence for healthcare and research, and the informed consent process involving human participants and their data.

Also read: India has world’s third-largest pool of AI talent: Bain-Microsoft report

The guideline has been formulated after extensive discussions with subject experts, researchers, and ethicists, said Dr Arora.

AI solution for challenges

AI can be the solution to significant challenges in healthcare like diagnosis and screening, therapeutics, preventive treatments, clinical decision-making, public health surveillance, complex data analysis, and predicting disease outcomes. This list is likely to grow in future, the document said.

The purpose of these guidelines is not to limit innovation or recommend any disease-specific diagnostic or therapeutic approach but to guide effective yet safe development, deployment, and adoption of AI-based technologies in biomedical research and healthcare delivery, it said.

These guidelines will be used by experts and ethics committees reviewing research proposals involving the use of AI-based tools and technologies.

(With agency inputs)

Read More
Next Story